GeneHealth - Your precision medicine

Dilated Cardiomyopathy 1y

Disease Details

Family Health Simplified

Buy Membership

Description: Dilated cardiomyopathy (DCM) is a condition where the heart's ability to pump blood is decreased because the left ventricle is enlarged and weakened.
Type: Dilated cardiomyopathy 1Y (DCM1Y) is inherited in an autosomal recessive manner.
Signs And Symptoms: ## Dilated Cardiomyopathy (DCM) - Signs and Symptoms

**Signs and Symptoms:**
- Shortness of breath (dyspnea), especially during exertion or when lying down
- Fatigue and general weakness
- Swelling (edema) in the legs, ankles, feet, and abdomen
- Rapid, pounding, or fluttering heartbeats (palpitations)
- Reduced ability to exercise or perform physical activities
- Persistent cough or wheezing with white or pink blood-tinged phlegm
- Increased need to urinate at night
- Weight gain from fluid buildup
- Chest pain or discomfort
- Lightheadedness, dizziness, or fainting

These symptoms result from the heart's reduced ability to pump blood effectively, leading to a buildup of fluid in various parts of the body and decreased oxygen supply.
Prognosis: Dilated cardiomyopathy (DCM) is a condition where the heart's ability to pump blood is decreased because the heart's main pumping chamber, the left ventricle, is enlarged and weakened. Prognosis for DCM can vary widely based on underlying causes, severity of the condition, and response to treatment. Some patients may manage well with medication and lifestyle changes, while others might experience progressive heart failure and complications. In severe cases, heart transplantation may be considered. Regular follow-up with a healthcare provider is crucial for managing the condition effectively.
Onset: Dilated cardiomyopathy can onset at any age, including infancy. It is characterized by the dilation of the heart's ventricles and impaired systolic function. Symptoms may gradually become noticeable or emerge suddenly, depending on the underlying cause.
Prevalence: The prevalence of dilated cardiomyopathy (DCM) can vary based on the population studied. Generally, DCM affects approximately 1 in 2,500 to 1 in 2,000 adults worldwide.
Epidemiology: Dilated cardiomyopathy (DCM) is a condition characterized by enlargement and weakening of the heart's main pumping chamber, the left ventricle. The epidemiology of DCM includes:

1. **Prevalence**: It affects approximately 1 in 250 individuals globally.
2. **Age**: While it can occur at any age, it is most commonly diagnosed in adults between the ages of 20 and 60.
3. **Gender**: It is more common in men than in women.
4. **Geography**: There are no significant geographic variations in its occurrence.
5. **Ethnicity**: African Americans have a higher prevalence compared to other ethnic groups.
6. **Risk Factors**: Includes genetic mutations, viral infections, autoimmune diseases, and exposure to toxins like alcohol or certain drugs.

For "nan," it is unclear what specific information is being requested regarding the epidemiology of DCM. If more context is provided, a more detailed answer can be given.
Intractability: Dilated cardiomyopathy (DCM) can be challenging to manage, and while it is not entirely "intractable," it is often chronic and requires ongoing treatment. Management typically includes medications to improve heart function, lifestyle changes, and in some cases, devices like pacemakers or defibrillators. Advanced cases may necessitate heart transplantation. The prognosis varies depending on the severity and response to treatment.
Disease Severity: Dilated cardiomyopathy (DCM) generally varies in severity depending on the individual case, ranging from mild to severe. The progression can be slow or rapid and may lead to complications such as heart failure, arrhythmias, or sudden cardiac death. The term "1y" might refer to a specific genetic form or subtype, which can influence severity and prognosis.
Healthcare Professionals: Disease Ontology ID - DOID:0110457
Pathophysiology: Dilated cardiomyopathy (DCM) is a condition characterized by the dilation and impaired contraction of the left or both ventricles. The pathophysiology involves several mechanisms, including genetic mutations, myocardial inflammation, and exposure to toxins (e.g., alcohol or cocaine) which lead to weakening of the heart muscle. This results in decreased systolic function, reduced cardiac output, and progressive heart failure. Genetic factors play a significant role, and mutations in genes encoding cytoskeletal, sarcomeric, and nuclear envelope proteins are commonly implicated. Over time, the heart chambers enlarge and the walls may become thinner, further exacerbating the functional decline.
Carrier Status: Carrier status for dilated cardiomyopathy typically refers to whether an individual carries a genetic mutation associated with the disease but may not manifest symptoms themselves. Specific details about the carrier status for "dilated_cardiomyopathy_1y" and "nan" are insufficient to provide a clear answer without additional context on genetic markers or detailed medical information.
Mechanism: Dilated cardiomyopathy (DCM) is a condition characterized by the enlargement and impaired contraction of the left or both ventricles of the heart.

**Mechanism:**
The heart muscle becomes weakened and loses the ability to pump blood effectively. The ventricles stretch and become dilated, which further weakens the cardiac muscle and worsens heart function. This can lead to heart failure and arrhythmias.

**Molecular Mechanisms:**
1. **Genetic Mutations:** Mutations in genes encoding sarcomeric proteins, cytoskeletal proteins, and nuclear envelope proteins can disrupt the structural integrity and function of cardiomyocytes.
2. **Inflammatory Processes:** Viral infections and autoimmune responses can induce inflammation and consequent damage to heart muscle cells.
3. **Oxidative Stress:** Increased production of reactive oxygen species (ROS) can damage cellular components and impair cardiac function.
4. **Calcium Handling:** Disruption in the regulation of calcium ions, crucial for contraction and relaxation of heart muscles, can lead to impaired contractility.
5. **Mitochondrial Dysfunction:** Impaired mitochondrial function can reduce ATP production, leading to energy deficits in cardiomyocytes.
6. **Neurohormonal Activation:** Chronic stimulation of the sympathetic nervous system and renin-angiotensin-aldosterone system can lead to detrimental remodeling of the heart tissue.

Understanding these molecular mechanisms helps in developing targeted therapies for dilated cardiomyopathy.
Treatment: Dilated cardiomyopathy (DCM) is typically managed with a combination of lifestyle modifications, medications, and sometimes surgical interventions. Although there are various subtypes and causes, general treatment options include:

1. **Medications**:
- **ACE Inhibitors** (e.g., enalapril, lisinopril): Help relax blood vessels and reduce the heart's workload.
- **Beta-Blockers** (e.g., metoprolol, carvedilol): Improve heart function and reduce symptoms.
- **Diuretics** (e.g., furosemide): Help reduce fluid buildup.
- **Aldosterone Antagonists** (e.g., spironolactone): Help remove excess sodium and fluid while preserving potassium.
- **Digoxin**: May be used to strengthen heart contractions.

2. **Lifestyle Modifications**:
- **Diet**: Low-sodium diet to manage fluid retention.
- **Exercise**: Regular physical activity, as recommended by a healthcare provider.
- **Alcohol**: Limiting or avoiding alcohol intake.

3. **Devices**:
- **Implantable Cardioverter-Defibrillator (ICD)**: May be implanted to prevent sudden cardiac death from arrhythmias.
- **Cardiac Resynchronization Therapy (CRT)**: Biventricular pacemaker to improve the timing of the heart’s contractions.

4. **Surgery**:
- In severe cases, a heart transplant might be considered.
- Left Ventricular Assist Devices (LVADs) may be used to support heart function.

The specific treatment plan should be tailored to the individual based on the severity and cause of the condition and the patient’s overall health. Regular follow-up with a cardiologist is essential.
Compassionate Use Treatment: For dilated cardiomyopathy (DCM), compassionate use treatment refers to accessing investigational drugs or therapies outside of clinical trials when no other treatment options are available. This is typically reserved for severe cases where standard treatments have failed.

Off-label treatments for DCM might include medications that are not specifically approved for DCM but are used because they can help manage symptoms or improve heart function. Examples include certain beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor blockers (ARBs).

Experimental treatments currently being investigated for DCM include gene therapy, stem cell therapy, and new pharmacological agents. These treatments are typically available only through clinical trials and are not yet widely available.

Patients interested in these treatment options should discuss them thoroughly with their healthcare provider to understand the potential benefits and risks.
Lifestyle Recommendations: For individuals with dilated cardiomyopathy (DCM), here are some general lifestyle recommendations:

1. **Medication Adherence**: Take prescribed medications regularly as advised by a healthcare provider.

2. **Diet**:
- Eat a heart-healthy diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats.
- Limit salt (sodium) intake to help control blood pressure and reduce fluid retention.
- Avoid excessive alcohol consumption.

3. **Exercise**:
- Engage in moderate physical activity as tolerated and recommended by a healthcare provider.
- Avoid strenuous activities unless specifically cleared by a doctor.

4. **Weight Management**: Maintain a healthy weight to reduce the strain on the heart.

5. **Monitor Symptoms**: Keep track of symptoms such as shortness of breath, swelling in the legs, or sudden weight gain, and report them to a healthcare provider promptly.

6. **Smoking Cessation**: Quit smoking and avoid exposure to secondhand smoke, as smoking can exacerbate heart conditions.

7. **Regular Check-ups**: Attend regular follow-up appointments with a healthcare provider to monitor the condition and adjust treatments as necessary.

8. **Limit Caffeine**: Moderate caffeine intake, as excessive consumption can exacerbate symptoms.

9. **Stress Management**: Practice stress-reducing techniques such as yoga, meditation, or deep-breathing exercises.

10. **Emergency Plan**: Develop an emergency plan and know when to seek immediate medical attention if symptoms worsen.

Always consult with a healthcare provider to tailor these recommendations to the specific needs and conditions of the individual.
Medication: For dilated cardiomyopathy (DCM), medications are aimed at managing symptoms and improving heart function. Common medications include:

1. **ACE Inhibitors**: To relax blood vessels and reduce the heart's workload (e.g., enalapril, lisinopril).
2. **Beta-Blockers**: To slow the heart rate and reduce blood pressure (e.g., metoprolol, carvedilol).
3. **Diuretics**: To help reduce fluid buildup in the body (e.g., furosemide, spironolactone).
4. **Aldosterone Antagonists**: To help remove excess sodium and water (e.g., eplerenone).
5. **Anticoagulants**: If there is a high risk of blood clots (e.g., warfarin).

These medications need to be tailored to each individual, often in combination, and require ongoing medical supervision. Always consult a healthcare provider for personalized treatment.
Repurposable Drugs: For dilated cardiomyopathy (DCM), there are several existing drugs that might be considered for repurposing to manage symptoms and progression of the disease. These include:

1. **Beta-blockers** (e.g., Carvedilol, Metoprolol): Used to manage heart failure symptoms and improve heart function.
2. **ACE inhibitors** (e.g., Enalapril, Lisinopril): Help to reduce heart workload and delay progression of heart failure.
3. **Angiotensin II receptor blockers (ARBs)** (e.g., Losartan, Valsartan): Alternatives to ACE inhibitors, used to reduce heart workload.
4. **Aldosterone antagonists** (e.g., Spironolactone, Eplerenone): Help to reduce fluid retention and heart failure symptoms.
5. **Diuretics** (e.g., Furosemide, Torsemide): Assist in reducing fluid overload and easing symptoms of heart failure.
6. **Digoxin**: Improves heart contractility and helps control heart rate.

Experimental approaches and newer therapies are continually being investigated, but the drugs listed are commonly used in clinical practice for managing DCM.
Metabolites: Dilated cardiomyopathy (DCM) is a condition characterized by the enlargement and weakening of the heart's ventricles. Regarding metabolites, there is ongoing research to understand their role in this condition. Specific metabolites associated with DCM can include abnormalities in energy metabolism, such as alterations in fatty acid and glucose metabolism. These changes can affect the heart muscle's efficiency and function. Unfortunately, the term "nan" doesn't provide enough context for a specific connection to dilated cardiomyopathy.
Nutraceuticals: For dilated cardiomyopathy (DCM), there is limited evidence directly supporting the use of nutraceuticals as a primary treatment. However, some nutraceuticals may support overall cardiovascular health and potentially benefit patients with DCM:

1. **Omega-3 Fatty Acids**: These can help reduce inflammation and improve heart function.
2. **Coenzyme Q10**: It may improve energy production in heart cells and enhance overall heart function.
3. **L-Carnitine**: It assists in energy production and has been suggested to benefit heart muscle cells.
4. **Taurine**: An amino acid that may aid in cardiac function and heart failure.

Patients should consult their healthcare providers before starting any new supplement.
Peptides: Dilated cardiomyopathy (DCM) is a condition where the heart becomes enlarged and cannot pump blood effectively. Currently, there is limited information on specific peptides directly used for its treatment. However, research into peptides and other molecular treatments is ongoing. Specific peptides used in a broader cardiovascular context include angiotensin receptor-neprilysin inhibitors, which can help manage heart failure, a common consequence of DCM. Always consult a medical professional for personalized treatment options.